The Medical Letter on Drugs and Therapeutics
FROM
ISSUE812
ISSUE812
February 23, 1990
Anistreplase for Acute Coronary Thrombosis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Anistreplase for Acute Coronary Thrombosis
February 23, 1990 (Issue: 812)
Anistreplase (Eminase - SmithKline Beecham, Upjohn), a plasminogen activator also known as APSAC, was recently approved by the US Food and Drug Administration (FDA) for intravenous (IV) thrombolytic treatment of coronary thrombosis. Three other...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.